Yvonne Christine Mårtensson

Président chez ORTOMA AB Fortune : 35 737 $ au 31/05/2026

Profil

Yvonne Christine Mårtensson currently works at Gynius AB, as Chief Executive Officer, Ortoma AB, as Chairman from 2023, Lyfstone AS, as Director, SwedenBIO Service AB, as Director, Inter Life Science AB, as Director, Pulsetten AB, as Director, Uniogen Oy, as Independent Director from 2022, Boule Diagnostics AB, as Independent Director, and Royal Swedish Academy of Engineering Sciences, as Member.
Ms. Mårtensson also formerly worked at CellaVision AB, as President & Chief Executive Officer from 2010 to 2014, Aerocrine AB, as Director, Biotage AB, as Independent Director, Ortivus AB, as Director, Elos Medtech AB, as Director from 2015 to 2017, Biolin Scientific AB, as Director, Arcoma AB, as Director, NsGene A, as Director, ScandiDos AB, as Director, SyntheticMR AB, as Director, IMIX Holding AB, as Director, Xvivo Perfusion AB, as Director, 3Brain AG, as Director, Vidhance AB, as Director from 2023 to 2025, YCM Consulting AB, as Director, and HemoCue AB, as Manager-Sales & Marketing.
Ms. Mårtensson received her Masters Business Admin degree in 1976 from the University of Lund and graduate degree from Linköping Institute of Technology.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ORTOMA AB CLASS B 0,09 %	31/12/2024	41 143 ( 0,09 % )	35 737 $	31/05/2026

Postes actifs de Yvonne Christine Mårtensson

Sociétés	Poste	Début
ORTOMA AB	Président	01/05/2023
BOULE DIAGNOSTICS AB	Directeur/Membre du Conseil	-
Pulsetten AB	Directeur/Membre du Conseil	-
Uniogen Oy	Directeur/Membre du Conseil	01/06/2022
Lyfstone AS	Directeur/Membre du Conseil	-
Royal Swedish Academy of Engineering Sciences	Corporate Officer/Principal	-
Gynius AB	Directeur Général	-
Inter Life Science AB	Directeur/Membre du Conseil	-
SwedenBIO Service AB	Directeur/Membre du Conseil	-

Anciens postes connus de Yvonne Christine Mårtensson

Sociétés	Poste	Fin
░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░